Kala Pharmaceuticals secures $22.5 million in Series B funding - MarketLine Financial Deals

Kala Pharmaceuticals secures $22.5 million in Series B funding

Kala Pharmaceuticals secures $22.5 million in Series B funding - MarketLine Financial Deals
Kala Pharmaceuticals secures $22.5 million in Series B funding
Published Apr 23, 2014
4 pages — Published Apr 23, 2014
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Kala Pharmaceuticals, Inc. has secured $22.5 million in Series B round of funding.

  
Source:
Document ID
MA146914_140428
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Kala Pharmaceuticals secures $22.5 million in Series B funding" Apr 23, 2014. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Kala-Pharmaceuticals-secures-22-5-million-in-Series-B-funding-2052-102411>
  
APA:
MarketLine Financial Deals. (2014). Kala Pharmaceuticals secures $22.5 million in Series B funding Apr 23, 2014. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Kala-Pharmaceuticals-secures-22-5-million-in-Series-B-funding-2052-102411>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.